Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2015 Nov 9:9:87-93.
doi: 10.4137/CMO.S30891. eCollection 2015.

Cachexia Index in Advanced Non-Small-Cell Lung Cancer Patients

Affiliations

Cachexia Index in Advanced Non-Small-Cell Lung Cancer Patients

Syed Hasan Raza Jafri et al. Clin Med Insights Oncol. .

Abstract

Introduction: Cancer cachexia affects many advanced non-small-cell lung cancer (NSCLC) patients. Cachexia index (CXI) was developed to assess the degree of cachexia in these patients.

Methods: Patients with metastatic NSCLC diagnosed between January 1, 2000, and June 30, 2011, at our institution were retrospectively studied. Abdominal computed tomography scans done within 1 month of diagnosis were reviewed to estimate skeletal muscle area (SMA) and skeletal muscle index (SMI) at the L3 level. CXI was developed as follows: [Formula: see text] where SMI is the skeletal muscle index, Alb is the serum albumin, and NLR is the neutrophil-to-lymphocyte ratio. Progression-free survival (PFS) and overall survival (OS) were estimated using the Kaplan-Meier method. Survival among various factors was calculated using the log-rank test. Multivariate Cox regression was used to perform survival analysis in order to estimate the effects of various factors.

Results: Patients were divided into two groups around the median into stage I cachexia (CXI ≥35, n = 56) and stage II cachexia (CXI <35, n = 56). Groups did not differ in age, gender, ethnicity, or histology of cancer. Patients with stage II cachexia had significantly worse PFS (2.45 vs 5.43 months, P < 0.0001) and OS (3.45 vs 8.8 months, P = 0.0001) than those with stage I cachexia. On multivariate analysis adjusting for gender, race, and histology, patients with stage II cachexia were found to have worse PFS (hazard ratio [HR] 1.94, 95% confidence interval [CI] 1.27-2.95) and OS (HR 1.53, 95% CI 1.0009-2.34).

Conclusion: The CXI is a novel index for estimating cachexia that also correlates with prognosis in both men and women with advanced NSCLC.

Keywords: cancer cachexia; lung cancer; sarcopenia; systemic inflammation.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Kaplan–Meier curve for progression-free survival (PFS) and overall survival (OS) in patients with stage I cachexia (CXI ≥35) and stage II cachexia (CXI <35).
Figure 2
Figure 2
Kaplan–Meier curve for progression-free survival and overall survival with stage I cachexia (CXI ≥35) and stage II cachexia (CXI <35) based on gender. Abbreviations: M, male; F, female.

References

    1. Siegel R, Ma J, Zou Z, Jamal A. Cancer statistics 2014. CA Cancer J Clin. 2014;64(1):9–29. - PubMed
    1. Wagner PD. Possible mechanisms underlying the development of cachexia in COPD. Eur Respir J. 2008;31(3):492–501. - PubMed
    1. Anker SD, Sharma R. The syndrome of cardiac cachexia. Int J Cardiol. 2002;85(1):51–66. - PubMed
    1. Von Roenn JH, Roth EL, Craig R. HIV-related cachexia: potential mechanisms and treatment. Oncology. 1992;49(2):50–4. - PubMed
    1. Fearon K, Strasser F, Anker SD, et al. Definition and classification of cancer cachexia: an international consensus. Lancet Oncol. 2011;12:489–95. - PubMed

LinkOut - more resources